Israel Active

Israel’s Oramed (see previously) has reported that its ORMD-0801 oral insulin candidate successfully reduced the liver fat in its Phase 2 trial on Type 2 diabetes patients with non-alcoholic steatohepatitis ("NASH").  There were no safety issues in the double-blind, multi-center trial.

Israel’s 6Degrees (see previously) has made significant progress with its MyMove wristband that allows people who can’t use their hands to operate any phone, laptop, or tablet. It includes having Tel Aviv municipality adopt the wristband to help people with disabilities come back to work.

Israeli-US startup Hour25.ai has developed an app that learns and monitors a user’s activity patterns and gives an alert whenever it detects inactivity, fatigue or distraction. It then suggests a personalized intervention, e.g., take a walk, or perform an optional exercise.

A Haifa University-led team of international scientists has discovered a method to identify early Parkinson’s Disease cases. Brain cells of PD patients die when they disconnect from the extracellular matrix. Early detection and subsequent treatment could halt this process.

Israel has taken delivery of second-generation coronavirus vaccines, updated to better battle new variants. They are expected to be in clinics by the end of September. The international scientific community is again looking to see how well these new vaccines protect Israelis.

The Israel Cancer Research Fund (ICRF) has awarded 83 cancer research grants (28 new and 55 continuing) worth almost $5 million for the 2022-2023 funding year. ICRF’s funding has now reached 2,730 grants totaling more than $87.5 million.

Israel’s Ibex Medical Analytics (see previously) has launched a new cancer detection platform - Galen 3.0 with improved AI algorithms to detect cancer in prostate, breast and gastric biopsies. It also calculates the aggressiveness of prostate cancer, reducing time and errors.

Tel Aviv University scientists have discovered that brain cells called astrocytes, which normally support brain function, are highjacked by tumors to block the immune system and feed the tumors. The scientists eliminated the astrocytes in the lab, and within days the brain tumors died.

Tel Aviv University researchers have identified two antibodies, TAU-1109 and TAU-2310, from recovered coronavirus patients that are 95% effective in neutralizing Covid-19 variants. When concentrated, they can be the basis for a one-time booster for all.

18-year-old Moriah had just completed a first-aid course with emergency NGO United Hatzalah, when she saw her 6-year-old sister Miriam choking on a candy. Moriah remembered the Heimlich maneuver. Within a few seconds the candy came out and Miriam started breathing once again.